ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,370.33
-0.55%
Dow Jones
39,672.58
-0.50%
Gold vs US Dollar
2,388.085
-1.38%
Brent Oil
81.705
-0.90%
Bitcoin
69,562.04
-0.81%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Integrated BioPharma Inc (QX) (INBP)

  7. Integrated BioPharma Inc (QX) (INBP) News

Integrated BioPharma (QX) (INBP)

Integrated BioPharma Inc (QX)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:INBP
DateTimeSourceHeadlineSymbolCompany
10/05/202421:39Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INBPIntegrated BioPharma Inc (QX)
10/05/202421:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:INBPIntegrated BioPharma Inc (QX)
12/02/202421:31Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INBPIntegrated BioPharma Inc (QX)
12/02/202421:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:INBPIntegrated BioPharma Inc (QX)
29/11/202323:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
29/11/202323:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
29/11/202322:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
27/11/202320:18Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INBPIntegrated BioPharma Inc (QX)
16/11/202321:18Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:INBPIntegrated BioPharma Inc (QX)
16/11/202321:13Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
16/11/202318:49Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
14/11/202318:12Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:INBPIntegrated BioPharma Inc (QX)
09/11/202319:26Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INBPIntegrated BioPharma Inc (QX)
09/11/202318:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:INBPIntegrated BioPharma Inc (QX)
27/10/202316:31Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:INBPIntegrated BioPharma Inc (QX)
21/09/202321:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
21/09/202320:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
21/09/202315:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
15/09/202322:20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INBPIntegrated BioPharma Inc (QX)
15/09/202321:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:INBPIntegrated BioPharma Inc (QX)
20/07/202320:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
19/07/202320:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
19/07/202320:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
19/07/202320:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
01/06/202319:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INBPIntegrated BioPharma Inc (QX)
01/06/202319:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INBPIntegrated BioPharma Inc (QX)
11/05/202320:38Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INBPIntegrated BioPharma Inc (QX)
21/03/202319:23Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INBPIntegrated BioPharma Inc (QX)
17/03/202316:57Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INBPIntegrated BioPharma Inc (QX)
10/02/202322:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INBPIntegrated BioPharma Inc (QX)
 Showing the most relevant articles for your search:USOTC:INBP

Your Recent History

LSE
VAST
Vast Resources
LSE
POLX
Polarean Imaging
LSE
GGP
Greatland Gold
LSE
ZED
Zenova
LSE
SCLP
Scancell
LSE
POS
Plexus
LSE
PHE
Powerhouse Energy
LSE
AGL
Angle
LSE
RKH
Rockhopper Exploration
LSE
TERN
Tern
LSE
LLOY
Lloyds Banking
LSE
KEFI
Kefi Gold And Copper
LSE
AAZ
Anglo Asian Mining
LSE
CHLL
Chill Brands
LSE
GKP
Gulf Keystone Petroleum
LSE
TW.
Taylor Wimpey
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved